Z, H., W, Y., A, G., A, B., P, M., IG, A., . . . N, M. (2026). Increased anti-nucleocapsid secretory IgA and consumption of complement component 3 in post-COVID syndrome patients. Frontiers in immunology, 17, 1822171. https://doi.org/10.3389/fimmu.2026.1822171
Chicago Style (17th ed.) CitationZ, Hai, et al. "Increased Anti-nucleocapsid Secretory IgA and Consumption of Complement Component 3 in Post-COVID Syndrome Patients." Frontiers in Immunology 17 (2026): 1822171. https://doi.org/10.3389/fimmu.2026.1822171.
MLA (9th ed.) CitationZ, Hai, et al. "Increased Anti-nucleocapsid Secretory IgA and Consumption of Complement Component 3 in Post-COVID Syndrome Patients." Frontiers in Immunology, vol. 17, 2026, p. 1822171, https://doi.org/10.3389/fimmu.2026.1822171.